Back
Pfizer Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
23
PFE
Pfizer
Last Price:
28.43
Seasonality Move:
2.8%
Sell
38
SRPT
Sarepta Therapeutics
Last Price:
128.81
Seasonality Move:
11.13%
Sell
23
Pfizer (PFE)
is a Sell
Is Pfizer a Buy, Sell or Hold?
- The current Pfizer [PFE] share price is $28.46. The Score for PFE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- PFE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $130.19. The Score for SRPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PFE Stock Price Chart
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $130.19
The current trend is moderately bullish and SRPT is experiencing slight selling pressure.
PFE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 42.39 | Sell |
| Chaikin Money Flow: | -20268674 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.6 - 29.42) | Sell |
| Bollinger Bands (100): | (28.1 - 29.74) | Sell |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.05 | Buy |
| Relative Strength Index (14 RSI): | 58.34 | Buy |
| Chaikin Money Flow: | -9031 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.84 - 128.84) | Buy |
| Bollinger Bands (100): | (123 - 147.2) | Sell |
PFE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.78 | Sell |
| 20-day SMA: | 28.99 | Sell |
| 50-day SMA: | 29.06 | Sell |
| 200-day SMA: | 28.2 | Buy |
| 8-day EMA: | 28.77 | Sell |
| 20-day EMA: | 28.96 | Sell |
| 50-day EMA: | 29.02 | Sell |
| 200-day EMA: | 29.38 | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 129.53 | Buy |
| 20-day SMA: | 124.83 | Buy |
| 50-day SMA: | 128.74 | Buy |
| 200-day SMA: | 130.35 | Sell |
| 8-day EMA: | 129.2 | Buy |
| 20-day EMA: | 127.16 | Buy |
| 50-day EMA: | 128.69 | Buy |
| 200-day EMA: | 127.96 | Buy |
Pfizer Earnings Growth & PFE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.34 per share, and an increase next year of $0.02 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.72 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.19 per share, and an increase next year of $8.77 per share.
Pfizer Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||